Prager GW - Search Results

1

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M, Fürnkranz K, Famler B, Schmeidl M, Minichsdorfer C, Zielinski C, Heller G, Prager GW. Bianconi D, et al. Among authors: prager gw. Transl Oncol. 2019 Jan;12(1):15-23. doi: 10.1016/j.tranon.2018.08.019. Epub 2018 Sep 20. Transl Oncol. 2019. PMID: 30245304 Free PMC article.

2

Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma.

Raderer M, Wöhrer S, Bartsch R, Prager G, Drach J, Hejna M, Gaiger A, Turetschek K, Jaeger U, Streubel B, Zielinski CC. Raderer M, et al. J Clin Oncol. 2005 Nov 20;23(33):8442-6. doi: 10.1200/JCO.2004.00.8532. J Clin Oncol. 2005. PMID: 16293875 Clinical Trial.

3

CD98hc (SLC3A2), a novel marker in renal cell cancer.

Prager GW, Poettler M, Schmidinger M, Mazal PR, Susani M, Zielinski CC, Haitel A. Prager GW, et al. Eur J Clin Invest. 2009 Apr;39(4):304-10. doi: 10.1111/j.1365-2362.2009.02096.x. Eur J Clin Invest. 2009. PMID: 19292886

4

Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.

Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, Cerny-Reiterer S, Lamm W, Kornek GV, Binder BR, Zielinski CC, Valent P. Prager GW, et al. Mol Oncol. 2010 Apr;4(2):150-60. doi: 10.1016/j.molonc.2010.01.002. Epub 2010 Jan 7. Mol Oncol. 2010. PMID: 20106729 Free PMC article.

5

The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration.

Poettler M, Unseld M, Mihaly-Bison J, Uhrin P, Koban F, Binder BR, Zielinski CC, Prager GW. Poettler M, et al. Among authors: prager gw. Thromb Haemost. 2012 Aug;108(2):357-66. doi: 10.1160/TH11-12-0868. Epub 2012 Jul 10. Thromb Haemost. 2012. PMID: 22782499

6

Soluble carcinoembryonic antigen activates endothelial cells and tumor angiogenesis.

Bramswig KH, Poettler M, Unseld M, Wrba F, Uhrin P, Zimmermann W, Zielinski CC, Prager GW. Bramswig KH, et al. Among authors: prager gw. Cancer Res. 2013 Nov 15;73(22):6584-96. doi: 10.1158/0008-5472.CAN-13-0123. Epub 2013 Oct 11. Cancer Res. 2013. PMID: 24121495

7

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior.

Poettler M, Unseld M, Braemswig K, Haitel A, Zielinski CC, Prager GW. Poettler M, et al. Among authors: prager gw. Mol Cancer. 2013 Dec 21;12:169. doi: 10.1186/1476-4598-12-169. Mol Cancer. 2013. PMID: 24359579 Free PMC article.

8

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer.

Prager GW, Braemswig KH, Martel A, Unseld M, Heinze G, Brodowicz T, Scheithauer W, Kornek G, Zielinski CC. Prager GW, et al. Cancer Sci. 2014 Aug;105(8):996-1001. doi: 10.1111/cas.12451. Epub 2014 Jul 31. Cancer Sci. 2014. PMID: 24850362 Free PMC article.

9

[Abscopal effect in the treatment of malignant melanoma].

Thallinger C, Prager G, Ringl H, Zielinski C. Thallinger C, et al. Hautarzt. 2015 Jul;66(7):545-8. doi: 10.1007/s00105-014-3567-8. Hautarzt. 2015. PMID: 25576145 German.

10

Angiogenesis in cancer: Anti-VEGF escape mechanisms.

Prager GW, Poettler M, Unseld M, Zielinski CC. Prager GW, et al. Transl Lung Cancer Res. 2012 Mar;1(1):14-25. doi: 10.3978/j.issn.2218-6751.2011.11.02. Transl Lung Cancer Res. 2012. PMID: 25806151 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page